Aptevo Therapeutics Inc (NASDAQ:APVO) has a beta value of -100.00% and has seen 2.22 shares traded in the last trading session. The company, currently valued at $3.17M, closed the last trade at $5.13 per share which meant it lost -$414.87 on the day or 4.17% during that session. The APVO stock price is -9361.4% off its 52-week high price of $485.37 and 45.22% above the 52-week low of $2.81. If we look at the company’s 10-day average daily trading volume, we find that it stood at 12.85 million shares traded. The 3-month trading volume is 1.44 shares.
Aptevo Therapeutics Inc (NASDAQ:APVO) trade information
Sporting 4.17% in the green in last session, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the APVO stock price touched $5.13 or saw a rise of 60.87%. Year-to-date, Aptevo Therapeutics Inc shares have moved -99.08%, while the 5-day performance has seen it change -12.76%. Over the past 30 days, the shares of Aptevo Therapeutics Inc (NASDAQ:APVO) have changed -32.72%. Short interest in the company has seen 9397.0 shares shorted with days to cover at 0.03.
Aptevo Therapeutics Inc (APVO) estimates and forecasts
The company’s shares have lost -94.63% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 79.32% 80.96% over the past 5 years.
APVO Dividends
Aptevo Therapeutics Inc is expected to release its next earnings report on 2025-May-15 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Aptevo Therapeutics Inc (NASDAQ:APVO)’s Major holders
Insiders own 3.11% of the company shares, while shares held by institutions stand at 3.31% with a share float percentage of 3.41%. Investors are also buoyed by the number of investors in a company, with Aptevo Therapeutics Inc having a total of 10.0 institutions that hold shares in the company.
